Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 2
1953 1
1955 1
1957 5
1958 2
1959 2
1960 1
1962 3
1963 5
1964 1
1965 3
1966 3
1967 2
1968 4
1969 2
1970 6
1971 6
1972 4
1973 1
1974 6
1975 5
1976 7
1977 2
1978 2
1979 5
1980 6
1981 6
1982 4
1983 1
1984 2
1985 2
1986 4
1987 7
1988 6
1989 5
1990 6
1991 5
1992 5
1993 6
1994 4
1995 5
1996 6
1997 5
1998 5
1999 10
2000 14
2001 20
2002 20
2003 16
2004 12
2005 21
2006 36
2007 36
2008 41
2009 37
2010 42
2011 43
2012 46
2013 30
2014 37
2015 35
2016 28
2017 24
2018 31
2019 28
2020 36
2021 43
2022 43
2023 38
2024 39
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

952 results

Results by year

Filters applied: . Clear all
Page 1
A randomized, open-label, phase 3 trial of pembrolizumab plus epacadostat versus sunitinib or pazopanib as first-line treatment for metastatic renal cell carcinoma (KEYNOTE-679/ECHO-302).
Lara PN Jr, Villanueva L, Ibanez C, Erman M, Lee JL, Heinrich D, Lipatov ON, Gedye C, Gokmen E, Acevedo A, Semenov A, Park SH, Gafanov RA, Kose F, Jones M, Du X, Munteanu M, Perini R, Choueiri TK, Motzer RJ. Lara PN Jr, et al. Among authors: semenov a. BMC Cancer. 2024 Jul 25;23(Suppl 1):1253. doi: 10.1186/s12885-023-10971-7. BMC Cancer. 2024. PMID: 39054430 Free PMC article. Clinical Trial.
Upright proton therapy for esthesioneuroblastoma: a single-institution experience.
Gordon K, Gulidov I, Smyk D, Semenov A, Golubev K, Lemaeva A, Koryakin S, Jumaniyazova E, Vishnyakova P, Eremina I, Fatkhudinov T, Kaprin A. Gordon K, et al. Among authors: semenov a. Front Oncol. 2024 Jan 30;14:1348291. doi: 10.3389/fonc.2024.1348291. eCollection 2024. Front Oncol. 2024. PMID: 38352894 Free PMC article.
Room Temperature Synthesis of Bioactive 1,2,4-Oxadiazoles.
Baykov SV, Shetnev AA, Semenov AV, Baykova SO, Boyarskiy VP. Baykov SV, et al. Among authors: semenov av. Int J Mol Sci. 2023 Mar 12;24(6):5406. doi: 10.3390/ijms24065406. Int J Mol Sci. 2023. PMID: 36982481 Free PMC article. Review.
[Metastatic risk factors in pheochromocytoma/paraganglioma].
Rebrova DV, Loginova OI, Vorobyev SL, Vorokhobina NV, Kozorezova ES, Indeykin FA, Savelyeva TV, Sleptsov IV, Chernikov RA, Fedorov EA, Semenov AA, Chinchuk IK, Shikhmagomedov SS, Alekseev MA, Krasnov LM, Rusakov VF. Rebrova DV, et al. Among authors: semenov aa. Probl Endokrinol (Mosk). 2023 Oct 4;70(2):37-45. doi: 10.14341/probl13331. Probl Endokrinol (Mosk). 2023. PMID: 38796759 Free PMC article. Review. Russian.
Role of pheophytin a in the primary charge separation of photosystem I from Acaryochloris marina: Femtosecond optical studies of excitation energy and electron transfer reactions.
Petrova AA, Casazza AP, Shelaev IV, Gostev FE, Aybush AV, Nadtochenko VA, Semenov AY, Santabarbara S, Cherepanov DA. Petrova AA, et al. Among authors: semenov ay. Biochim Biophys Acta Bioenerg. 2023 Aug 1;1864(3):148984. doi: 10.1016/j.bbabio.2023.148984. Epub 2023 May 13. Biochim Biophys Acta Bioenerg. 2023. PMID: 37187220 Free article.
952 results